erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
.
daily pilot.
.
.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies..